A Director at Corcept Therapeutics Inc (CORT) is Buying Shares


Today, a Director at Corcept Therapeutics Inc (NASDAQ: CORT), Leonard G. Baker, bought shares of CORT for $1.32M.

Following this transaction Leonard G. Baker’s holding in the company was increased by 2.34% to a total of $59.83 million.

See today’s analyst top recommended stocks >>

Based on Corcept Therapeutics Inc’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $62.31 million and quarterly net profit of $18.2 million. In comparison, last year the company earned revenue of $35.56 million and had a net profit of $12.65 million. CORT’s market cap is $1.5B and the company has a P/E ratio of 11.24. Currently, Corcept Therapeutics Inc has an average volume of 894.7K.

Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $19.33, reflecting a -32.5% downside. Seven different firms, including B.Riley FBR and Cowen & Co., currently also have a Buy rating on the stock.

The insider sentiment on Corcept Therapeutics Inc has been positive according to 20 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts